Blood Protein Levels can Show Risk of Developing Asthma

by Medindia Content Team on  April 13, 2008 at 1:26 PM Respiratory Disease News
RSS Email Print This Page Comment bookmark
Font : A-A+

Blood Protein Levels can Show Risk of Developing Asthma
US researchers say they have identified gene variants which are associated with increased susceptibility to asthma and reduced lung function.

And these variants in a gene called CHI3L1 can be measured by checking levels of an inherited blood protein.

Apparently the gene variants regulate the level of a blood protein called YKL-40, which is high in people with asthma and correlate with asthma severity. This new research shows that the YLKL-40 protein is inherited, and can be measured from birth.

The research was sponsored by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.

Building on the previous finding that the protein is a blood marker for asthma, researchers looked at the gene that regulates the protein. The relationship between the gene, the protein and asthma was first seen in a genetically and environmentally similar population, 700 members of an isolated religious community, the Hutterites, who are closely related and of European descent.

The close-knit community has little exposure to smoking and similar exposures to environmental triggers for asthma. These factors make it easier to identify small differences in the genetic code, said, Elizabeth G. Nabel, director, NHLBI.

Researchers then confirmed the connection between the gene and YKL-40 protein in three additional, more genetically diverse white groups in Chicago, Wisconsin, and Freiburg, Germany.

In two of those populations, they confirmed the connection between the gene variants and asthma. One of the three groups, made up of 178 American children studied from birth in the NHLBI-funded Childhood Origins of Asthma (COAST) study, did not yet show a relationship between the gene and diagnosed asthma, but showed that the associations between YKL-40 levels and the gene variants were present at birth.

"YKL-40 appears to serve as a marker for genetic susceptibility to asthma and decline in lung function," said James P. Kiley director, NHLBI Division of Lung Diseases. "These findings will help pave the way for more research on pre-empting the development of disease."

"Knowing the variations in this one gene may help us learn more about how immune system development affects the risk of developing asthma," said Carole Ober, Department of Human Genetics, University of Chicago, and study author.

YKL-40 is a chitinase-like protein; chitinases are enzymes, which break down chitins. Chitin is an element that comprises the exoskeletons of dust mites, cockroaches, fungi and parasites -- all known to be allergenic and related to asthma.

YKL-40 does not have chitinase enzyme activity but is thought to play an important role in immune responses to chitin or other airborne particles. These proteins have been shown to play a role in animal models of asthma as having an important effect on airway inflammation.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Asthma Thalassemia Diet and Nutrition Tips for Athletes Blood in Stools - Symptom Evaluation Bombay Blood Group 

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive